ScreenPoint Medical has raised $28 million in funding with the help of Insight Partners. Existing investors provided support, including the company’s founders Siemens Healthineers and Oost NL. University Radiology Group (URG), a provider of radiology and teleradiology services in the USA, has also participated.
The funding will be used to accelerate commercial growth of Transpara AI breast care software, which uses machine learning technology and databases of screening mammograms to improve early diagnosis of breast cancer. The investment will enable further research and development and expansion of the product portfolio.
“We are excited about this funding and the opportunity to work with the Insight Partners team to continue scaling the company,” said ScreenPoint Medical ceo Nico Karssemeijer.
“We are also delighted with the participation of URG in this round. Breast imaging practice in the USA is different to the EU, and the partnership with URG brings clinical expertise, which is extremely valuable for further expansion in America.”
Picture: Funding will help accelerate commercial growth of the Transpara AI breast care software.
Published on page 24 of the September 2021 issue of RAD Magazine.